Myonexus Therapeutics

About:

Myonexus Therapeutics is a clinical stage gene therapy company developing first ever treatments for Limb-girdle muscular dystrophy types.

Website: http://www.myonexustx.com

Top Investors: Sarepta Therapeutics, CincyTech, Rev1 Ventures, Jain Foundation, GFB ONLUS

Description:

Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for Limb-girdle muscular dystrophy (LGMD) Types 2D, 2B, 2E, 2L, and 2C based on research at Nationwide Children’s Hospital, a global leader in muscular dystrophy gene therapy discovery and translational research.